logo

Lexeo Therapeutics Inc: Navigating Market Fluctuations with a 104.49M Market Cap

Lexeo Therapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $19.50 on 07/11/24, while the lowest price for the same duration was marked at $3.37 on 02/26/25.

52-week price history of LXEO Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Lexeo Therapeutics Inc’s current trading price is -83.79% away from its 52-week high, while its distance from the 52-week low is -6.23%. The stock’s price range during this period has spanned from $3.37 to $19.50. In the Healthcare sector, the Lexeo Therapeutics Inc’s shares surpassed a trading volume of approximately 0.79 million for the day, which was noticeably higher compared to the average daily volume of 9.0.25 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Lexeo Therapeutics Inc (LXEO) has experienced a quarterly decline of -49.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 104.49M and boasts a workforce of 58 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 6.89, with a change in price of -5.58. Similarly, Lexeo Therapeutics Inc recorded 341,923 in trading volume during the last 100 days, posting a change of -63.84%.

Examining LXEO’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for LXEO stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.

LXEO Stock Stochastic Average

Today, Lexeo Therapeutics Inc’s raw stochastic average for the past 50 days stands at 1.05%, indicating a decline from the raw stochastic average of the last 20 days, which was 1.71%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 4.58% and 5.64% respectively.

LXEO Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -51.98% this year. Over the last six months, there has been a stronger performance of -73.78%. The price of LXEO leaped by -46.17% during the last 30 days period. For the last 5-days stocks have slided -29.15%.

Most Popular